Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaussen

Showing results (161-170 of 183) with videos related to

Pageof 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2012
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclassesW E Pierceall, K A Olaussen, V Rousseau, et al.
Journal of Medical Internet Research|February 18, 2025
Simulation-Based Learning Supported by Technology to Enhance Critical Thinking in Nursing Students: Scoping ReviewHege Vistven Stenseth, Simen A Steindal, Marianne Trygg Solberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2024
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven MalignanciesFrancesco Facchinetti, Yohann Loriot, Floriane Brayé, et al.
ESMO Open|January 19, 2018
TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinomaCharlotte Leduc, Julien Adam, Emilie Louvet, et al.
Cancer Research|July 10, 2007
A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinibThibault de La Motte Rouge, Lorenzo Galluzzi, Ken A Olaussen, et al.
JMIR Research Protocols|April 4, 2022
Simulation-Based Learning Supported by Technology to Enhance Critical Thinking in Nursing Students: Protocol for a Scoping ReviewHege Vistven Stenseth, Simen Alexander Steindal, Marianne Trygg Solberg, et al.
The Prostate|November 11, 2021
Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomyAnne M A Tryggestad, Karol Axcrona, Ulrika Axcrona, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2018
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung CancerSiddhartha Devarakonda, Federico Rotolo, Ming-Sound Tsao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2022
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patientsJ Chen, F Facchinetti, F Braye, et al.
Cancer Discovery|June 28, 2023
Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial CancerFrancesco Facchinetti, Antoine Hollebecque, Floriane Braye, et al.
Pageof 19

Showing results (161-170 of 183) with videos related to

Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2012
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclassesW E Pierceall, K A Olaussen, V Rousseau, et al.
Journal of Medical Internet Research|February 18, 2025
Simulation-Based Learning Supported by Technology to Enhance Critical Thinking in Nursing Students: Scoping ReviewHege Vistven Stenseth, Simen A Steindal, Marianne Trygg Solberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2024
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven MalignanciesFrancesco Facchinetti, Yohann Loriot, Floriane Brayé, et al.
ESMO Open|January 19, 2018
TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinomaCharlotte Leduc, Julien Adam, Emilie Louvet, et al.
Cancer Research|July 10, 2007
A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinibThibault de La Motte Rouge, Lorenzo Galluzzi, Ken A Olaussen, et al.
JMIR Research Protocols|April 4, 2022
Simulation-Based Learning Supported by Technology to Enhance Critical Thinking in Nursing Students: Protocol for a Scoping ReviewHege Vistven Stenseth, Simen Alexander Steindal, Marianne Trygg Solberg, et al.
The Prostate|November 11, 2021
Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomyAnne M A Tryggestad, Karol Axcrona, Ulrika Axcrona, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2018
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung CancerSiddhartha Devarakonda, Federico Rotolo, Ming-Sound Tsao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2022
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patientsJ Chen, F Facchinetti, F Braye, et al.
Cancer Discovery|June 28, 2023
Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial CancerFrancesco Facchinetti, Antoine Hollebecque, Floriane Braye, et al.
Pageof 19